Dispute over patent rights to CRISPR-Cas9 renewed by patent office 27 June 2019 | By Drug Target Review The patent office has declared an interference between 10 University of California (UC) patent applications.
Medical journals found to restrict access to pharma industry research 27 June 2019 | By Victoria Rees (Drug Target Review) A new report has stated that the majority of medical journals restrict their content for pharmaceutical industry professionals.
Government letter advises pharma industry for no-deal Brexit 27 June 2019 | By Victoria Rees (Drug Target Review) The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
Potential drug target for Alzheimer’s identified 27 June 2019 | By Drug Target Review New research has identified an enzyme which causes degradation of dendritic spines, pointing to a drug target for Alzheimer’s.
New humanised mouse model developed 26 June 2019 | By Drug Target Review Researchers have announced a humanised mouse model which can be used in drug development processes.
Research shows pancreatitis biomarker linked to pancreatic cancer 25 June 2019 | By Victoria Rees (Drug Target Review) A study has discovered that a biomarker associated with pancreatitis is involved in its development to pancreatic cancer.
Neurodegeneration enzyme identified in mouse models 25 June 2019 | By Drug Target Review A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
Gene discovery could make cancer therapies more effective 25 June 2019 | By Victoria Rees (Drug Target Review) A recent study has identified the DBC1 gene which leaves cancer cells more exposed to therapies.
Job cuts limit cardiovascular and diabetes research and development 25 June 2019 | By Drug Target Review Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
Scientists have discovered important redundancies in T cells 21 June 2019 | By Drug Target Review Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
New method for developing medical imaging tracers discovered 21 June 2019 | By Drug Target Review A new medical imaging tracing method has been discovered by scientists which can better track drugs in the body.
Research identifies cells which contribute to inflammatory diseases 21 June 2019 | By Victoria Rees (Drug Target Review) A new study has shown that there are two populations of cells in the gut which leads to drug development potential.
New model found to improve drug development in pre-clinical trials 20 June 2019 | By Drug Target Review Researchers have successfully created a multi-organ in vitro model to test toxicity and efficacy of drugs.
Study identifies two enzymes which protect tumour cells 20 June 2019 | By Victoria Rees (Drug Target Review) Researchers have found an enzyme and its counterpart which inhibit T-cells from attacking tumour cells.
Longest successful gene expression raises hopes for gene editing therapies 20 June 2019 | By Victoria Rees (Drug Target Review) A study has reported that genes delivered to rhesus monkeys are still being expressed four years later.
